H.I.S Yönetim

Yönetim kriter kontrolleri 2/4

H.I.S CEO'su Motoshi Yada, Jan2022 tarihinde atandı, in görev süresi 2.83 yıldır. şirketin hisselerinin 0.009% doğrudan sahiptir ve bu hisselerin değeri ¥ 12.87M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.8 yıl ve 7.8 yıldır.

Anahtar bilgiler

Motoshi Yada

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	2.8yrs
CEO sahipliği	0.009%
Yönetim ortalama görev süresi	2.8yrs
Yönetim Kurulu ortalama görev süresi	7.8yrs

Son yönetim güncellemeleri

Recent updates

CEO

Motoshi Yada (63 yo)

2.8yrs

Görev süresi

Mr. Motoshi Yada serves as the Chief Executive Officer of H.I.S. Co. Ltd. since February 2023 and has been its Director since January 2020.He served as the Chief Operating Officer of H.I.S. Co. Ltd. since...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Motoshi Yada	President	2.8yrs	Veri yok	0.0094% ¥ 12.9m
Osamu Hanasaki	Executive Officer	no data	Veri yok	Veri yok
Kiwamu Fukushima	Corporate Officer	no data	Veri yok	Veri yok
Atsushi Yamanobe	Senior Executive Officer	2.1yrs	Veri yok	0.012% ¥ 16.5m
Tatsuya Nakamori	Senior MD & Director	6.8yrs	Veri yok	0.041% ¥ 57.0m
Masayuki Oda	MD & Director	6.8yrs	Veri yok	0.013% ¥ 18.4m
Hideo Hatano	Corporate Officer & Head of Overseas Sales Division	no data	Veri yok	Veri yok
Yuji Iwama	Corporate Officer & Head of Chubu Area Sales Division	no data	Veri yok	Veri yok
Hidetaka Sawada	Senior Executive Officer	2yrs	Veri yok	0.88% ¥ 1.2b
Katsu Segawa	Corporate Officer	no data	Veri yok	Veri yok

2.8yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim: 9603 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Motoshi Yada	President	4.8yrs	Veri yok	0.0094% ¥ 12.9m
Atsushi Yamanobe	Senior Executive Officer	8.8yrs	Veri yok	0.012% ¥ 16.5m
Tatsuya Nakamori	Senior MD & Director	14.8yrs	Veri yok	0.041% ¥ 57.0m
Masayuki Oda	MD & Director	8.8yrs	Veri yok	0.013% ¥ 18.4m
Hidetaka Sawada	Senior Executive Officer	4.8yrs	Veri yok	0.88% ¥ 1.2b
Hideo Sawada	Director	43.9yrs	JP¥125.00m	30.27% ¥ 41.6b
Tsunekazu Umeda	Outside Independent Director	8.8yrs	Veri yok	Veri yok
Sonoko Sekita	Director	8.8yrs	Veri yok	0.033% ¥ 46.0m
Mutsumi Gomi	Director	6.8yrs	Veri yok	0.011% ¥ 14.7m
Junko Owada	Independent Outside Director	1.8yrs	Veri yok	0.0013% ¥ 1.8m
Atsushi Nabeshima	Independent Outside Director and Audit & Supervisory Committee Member	3.8yrs	Veri yok	0.0013% ¥ 1.8m
Hiroto Kaneko	Independent Outside Director and Member of Audit & Supervisory Committee	1.8yrs	Veri yok	Veri yok

7.8yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 9603 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.8 yıldır).

H.I.S Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

H.I.S. Co., Ltd., Annual General Meeting, Jan 25, 2024

H.I.S. Co., Ltd., Annual General Meeting, Jan 26, 2023

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Now 20% undervalued

We Think H.I.S (TSE:9603) Is Taking Some Risk With Its Debt

H.I.S. Co., Ltd. to Report Fiscal Year 2024 Results on Dec 13, 2024

Why H.I.S. Co., Ltd. (TSE:9603) Could Be Worth Watching

Third quarter 2024 earnings: EPS exceeds analyst expectations

Now 21% undervalued after recent price drop

What You Can Learn From H.I.S. Co., Ltd.'s (TSE:9603) P/E

Now 27% undervalued after recent price drop

H.I.S. Co., Ltd. to Report Q3, 2024 Results on Sep 13, 2024

Now 13% undervalued after recent price drop

Second quarter 2024 earnings: EPS exceeds analyst expectations

H.I.S. Co., Ltd. to Report Q2, 2024 Results on Jun 14, 2024

New major risk - Financial position

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

H.I.S. Co., Ltd., Annual General Meeting, Jan 25, 2024

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates upgraded to JP¥46.22 loss, revenue downgraded

H.I.S. Co., Ltd. to Report Fiscal Year 2023 Results on Dec 15, 2023

Consensus EPS estimates fall by 15%

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

H.I.S. Co., Ltd. to Report Q3, 2023 Results on Sep 13, 2023

Consensus EPS estimates upgraded to JP¥65.24 loss, revenue downgraded

New major risk - Financial position

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus revenue estimates decrease by 15%, EPS upgraded

H.I.S. Co., Ltd. to Report Q2, 2023 Results on Jun 14, 2023

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates fall by 74%, revenue upgraded

H.I.S. Co., Ltd. to Report Q1, 2023 Results on Mar 15, 2023

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

H.I.S. Co., Ltd., Annual General Meeting, Jan 26, 2023

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus forecasts updated

H.I.S. Co., Ltd. to Report Fiscal Year 2022 Results on Dec 15, 2022

Less than half of directors are independent

Price target decreased to JP¥1,967

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus forecasts updated

A private equity fund managed by PAG Asia Capital entered into a share transfer agreement to acquire 66.67% stake in Huis Ten Bosch Co., Ltd. from H.I.S. Co., Ltd. (TSE:9603) for ¥66.7 billion.

A private equity fund managed by PAG Asia Capital entered into a share transfer agreement to acquire 66.67% stake in Huis Ten Bosch Co., Ltd. from H.I.S. Co., Ltd. (TSE:9603) for ¥66.7 billion.

H.I.S. Co., Ltd. to Report Q3, 2022 Results on Sep 13, 2022

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

H.I.S. Co., Ltd. to Report Q2, 2022 Results on Jun 13, 2022

Less than half of directors are independent

Consensus estimates of losses per share improve by 15%

Price target decreased to JP¥2,217

Consensus forecasts updated

H.I.S. Co., Ltd. to Report Q1, 2022 Results on Mar 17, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates fall by 12%

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus revenue estimates fall by 15%

Consensus revenue estimates fall to JP¥127.8b

H.I.S. Co., Ltd. announced that it has received ¥2.556278412 billion in funding from Pacific Alliance Investment Management Limited

Second quarter 2021 earnings released: JP¥233 loss per share (vs JP¥98.10 loss in 2Q 2020)

Consensus revenue estimates fall to JP¥214.9b

Price target increased to JP¥2,343

Consensus EPS estimates fall to -JP¥389

Price target increased to JP¥2,088

First quarter 2021 earnings released: JP¥127 loss per share (vs JP¥37.92 profit in 1Q 2020)

Analysts lower EPS estimates to -JP¥192

H.I.S. Co., Ltd. to Report Q1, 2021 Results on Mar 15, 2021

New 90-day high: JP¥2,084

Full year 2020 earnings released: JP¥433 loss per share (vs JP¥214 profit in FY 2019)

Revenue beats expectations, earnings disappoint

New 90-day high: JP¥1,782

Price target raised to JP¥1,813

Analysts update estimates

Analysts update estimates

Full year 2020 earnings released: JP¥433 loss per share